These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 170941)

  • 101. New procedures to measure synthase and phosphatase activities of bisphosphoglycerate mutase. Interest for development of therapeutic drugs.
    Ravel P; Garel MC; Toullec D
    C R Acad Sci III; 1997 Jan; 320(1):27-33. PubMed ID: 9099261
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Vanadate inhibits 2,3-bisphosphoglycerate dependent phosphoglycerate mutases but does not affect the 2,3-bisphosphoglycerate independent phosphoglycerate mutases.
    Carreras J; Bartrons R; Grisolía S
    Biochem Biophys Res Commun; 1980 Oct; 96(3):1267-73. PubMed ID: 6254527
    [No Abstract]   [Full Text] [Related]  

  • 103. [Documentation of forensic blood typing data].
    Heide KG; Steigleder E
    Z Rechtsmed; 1970; 67(4):211-7. PubMed ID: 4320114
    [No Abstract]   [Full Text] [Related]  

  • 104. Thermal inactivation differences of phosphofructokinase in erythrocytes from genetically selected high and low DPG rat strains.
    Chassin SL; Kruckeberg WC; Brewer GJ
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1306-11. PubMed ID: 151544
    [No Abstract]   [Full Text] [Related]  

  • 105. Purification and properties of 2, 3-diphosphoglyceric acid phosphatase from human erythrocytes.
    Harkness DR; Roth S
    Biochem Biophys Res Commun; 1969 Mar; 34(6):849-56. PubMed ID: 4305326
    [No Abstract]   [Full Text] [Related]  

  • 106. Sequence of the human erythrocyte phosphoglycerate mutase by microsequencer and mass spectrometry.
    Blouquit Y; Calvin MC; Rosa R; Promé D; Promé JC; Pratbernou F; Cohen-Solal M; Rosa J
    J Biol Chem; 1988 Nov; 263(32):16906-10. PubMed ID: 2846554
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Appendix II. The catalytic and stability properties of phosphorylated mammalian phosphoglycerate mutase.
    McWilliams AD; Hass LF
    J Biol Chem; 1986 Sep; 261(27):12722. PubMed ID: 3017987
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effect of detergents and homogenization on adenosine kinase and adenosine deaminase of human erythrocyte ghosts.
    Mustafa SJ; Rubio R; Berne RM
    Proc Soc Exp Biol Med; 1972 Oct; 141(1):161-3. PubMed ID: 5082289
    [No Abstract]   [Full Text] [Related]  

  • 109. The 2,3-diphosphoglyceric acid phosphatase activity of phosphoglyceric acid mutase purified from human erythrocytes.
    Harkness DR; Thompson W; Roth S; Grayson V
    Arch Biochem Biophys; 1970 May; 138(1):208-19. PubMed ID: 4315693
    [No Abstract]   [Full Text] [Related]  

  • 110. 2,3-diphosphoglycerate phosphatase from human erythrocytes. General properties and activation by anions.
    Rose ZB; Liebowitz J
    J Biol Chem; 1970 Jun; 245(12):3232-41. PubMed ID: 4317427
    [No Abstract]   [Full Text] [Related]  

  • 111. A facile radio-isotopic assay for phosphoribomutase activity in human red blood cells.
    Pérignon JL; Houllier AM; Cartier PH
    Clin Chim Acta; 1983 Apr; 129(3):365-70. PubMed ID: 6303632
    [No Abstract]   [Full Text] [Related]  

  • 112. Human phosphoribosylpyrophosphate synthetase: relation of activity and quaternary structure.
    Becker MA; Meyer LJ; Huisman WH; Lazar CS; Adams WB
    Adv Exp Med Biol; 1977; 76A():71-9. PubMed ID: 193379
    [No Abstract]   [Full Text] [Related]  

  • 113. Purification of human erythrocyte phosphoglyceromutase.
    Rosa R; Calvin MC; Prehu MO; Arous N
    J Chromatogr; 1984 Feb; 285(1):203-9. PubMed ID: 6323501
    [No Abstract]   [Full Text] [Related]  

  • 114. The purification and properties of diphosphoglycerate mutase from human erythrocytes.
    Rose ZB
    J Biol Chem; 1968 Sep; 243(18):4810-20. PubMed ID: 5687724
    [No Abstract]   [Full Text] [Related]  

  • 115. Factors affecting the concentration of 2,3-diphosphoglycerate in erythrocytes.
    Luque J; Pinilla M; Ventura ME; Santos-Ruiz A
    FEBS Lett; 1972 Jun; 23(1):31-3. PubMed ID: 4343617
    [No Abstract]   [Full Text] [Related]  

  • 116. Dependence of human erythrocyte PRPP synthetase specific activity on concentration.
    Sperling O; Boer P; Persky-Brosh S; De Vries A
    FEBS Lett; 1972 Nov; 27(2):229-30. PubMed ID: 4352020
    [No Abstract]   [Full Text] [Related]  

  • 117. Surface specializations of hydra cells: the effect of enzyme inhibitors on ferritin uptake.
    Lentz TL; Barrnett RJ
    J Ultrastruct Res; 1965 Aug; 13(1):192-211. PubMed ID: 4378805
    [No Abstract]   [Full Text] [Related]  

  • 118. Raised monophosphatase activity in schizophrenic patients.
    Zilberman-Kaufman M; Agam G; Moscowits L; Livne AA; Belmaker RH
    Clin Chim Acta; 1992 Jul; 209(1-2):89-93. PubMed ID: 1327586
    [No Abstract]   [Full Text] [Related]  

  • 119. Phosphoglycerate kinase: an X-linked polymorphism in man.
    Chen SH; Malcolm LA; Yoshida A; Giblett ER
    Am J Hum Genet; 1971 Jan; 23(1):87-91. PubMed ID: 5581984
    [No Abstract]   [Full Text] [Related]  

  • 120. Induction of 2,3-bisphosphoglycerate synthase in Friend leukemia cells.
    Narita H; Yanagawa S; Sasaki R; Chiba H
    Biochem Biophys Res Commun; 1981 Nov; 103(1):90-6. PubMed ID: 6274349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.